Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LOXO

Loxo Oncology (LOXO) Stock Price, News & Analysis

Loxo Oncology logo

About Loxo Oncology Stock (NASDAQ:LOXO)

Advanced Chart

Key Stats

Today's Range
$234.66
$234.66
50-Day Range
N/A
52-Week Range
$101.70
$234.93
Volume
400 shs
Average Volume
565,561 shs
Market Capitalization
$7.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LOXO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Loxo Oncology and its competitors with MarketBeat's FREE daily newsletter.

LOXO Stock News Headlines

This Social Security Shift Could Boost Benefits by 400%
If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.
Q3 2024 Eli Lilly and Co Earnings Call
See More Headlines

LOXO Stock Analysis - Frequently Asked Questions

Loxo Oncology Inc (NASDAQ:LOXO) released its quarterly earnings results on Thursday, August, 9th. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, topping analysts' consensus estimates of ($0.54) by $0.15. The biopharmaceutical company earned $42.60 million during the quarter, compared to the consensus estimate of $32.36 million. Loxo Oncology had a negative trailing twelve-month return on equity of 16.42% and a negative net margin of 43.49%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Loxo Oncology investors own include Meta Platforms (META), Bristol Myers Squibb (BMY), NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), GW Pharmaceuticals (GWPH) and Micron Technology (MU).

Company Calendar

Last Earnings
8/09/2018
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LOXO
CIK
1581720
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.31)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$148.87 million
Net Margins
-43.49%
Pretax Margin
N/A
Return on Equity
-16.42%
Return on Assets
-8.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.62
Quick Ratio
3.62

Sales & Book Value

Annual Sales
$21.30 million
Price / Sales
337.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.63 per share
Price / Book
18.58

Miscellaneous

Outstanding Shares
30,610,000
Free Float
N/A
Market Cap
$7.18 billion
Optionable
Optionable
Beta
2.51
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:LOXO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners